{"pub": "financialpost", "url": "https://globenewswire.com/news-release/2019/10/11/1928756/0/en/Isracann-Biosciences-Announces-Completion-of-the-Acquisition-of-Isracann-Holdings-Inc.html", "downloaded_at": "2019-10-11 19:42:13.358750+00:00", "title": "Isracann Biosciences Announces Completion of the Acquisition of Isracann Holdings Inc.", "language": "en", "text": "VANCOUVER, British Columbia, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (fka Atlas Blockchain Group Inc.) (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the \u201cCompany\u201d) is pleased to announce that it has completed its previously announced acquisition (the \u201cTransaction\u201d) of Isracann Holdings Inc. (formerly, Isracann Biosciences Inc.) (\u201cIsracann\u201d). Terms of the Transaction were set out in a share exchange agreement entered into on March 12, 2019, between the Company, Isracann and the shareholders of Isracann. The Transaction was approved at a special meeting of the shareholders of the Company held on July 5, 2019. The Transaction constitutes a \u201cfundamental change\u201d pursuant to Policy 8 \u2013 Fundamental Changes and Change of Business of the Canadian Securities Exchange (the \u201cCSE\u201d) and the Company will carry on the business of Isracann, which is now a wholly owned subsidiary of the Company.\n\n\n\nName Change and Consolidation\n\nIn connection with the Transaction, the Company consolidated its common shares on the basis of one post-consolidation share for each three pre-consolidation shares (the \u201cConsolidation\u201d) and changed its name to \u201cIsracann Biosciences Inc.\u201d.\n\nBoard of Directors\n\nThe Company is pleased to announce its board of directors following completion of the Transaction is as follows: Darryl Jones, Sean Bromley, Yana Popova, Desmond Balakrishnan and Dr. Irit Arbel.\n\nIn addition, the Company is pleased to announce its executive management as follows:\n\nDarryl Jones \u2013 Chief Executive Officer and President\n\nYana Popova \u2013 Chief Financial Officer and Corporate Secretary\n\nIsrael Moseson \u2013 Chief Operating Officer\n\nEscrow Release\n\nFurther to a previously announced private placement of subscription receipts of the Company for gross proceeds of $10,110,211 (the \u201cFinancing\u201d), the Company is pleased to announce that it has satisfied the escrow release conditions and the net proceeds have been released to the Company. The securities issued pursuant to the Financing are subject to a four month hold period from the escrow release date.\n\nCSE Listing\n\nThe CSE issued its conditional approval of the Transaction on September 23, 2019. The Company\u2019s post-Consolidation common shares will resume trading on the CSE under the new ticker symbol \u201cIPOT\u201d after the CSE\u2019s conditions for listing are satisfied and the CSE issues its final exchange bulletin confirming the completion of the Transaction.\n\nAdditional information in respect of the Company\u2019s business and the Transaction will be available in the Company\u2019s listing statement which will be filed under Company\u2019s profile on www.sedar.com upon receipt of the CSE\u2019s final approval.\n\nAbout Isracann Biosciences Inc.\n\nIsracann is an Israeli-based cannabis company focused on becoming a premier cannabis producer offering low-cost production targeting undersupplied, major European marketplaces. Based in Israel's agricultural sector, Isracann will leverage its development within the most experienced country in the world with respect to cannabis research. The Company has secured agreements within Israel for medicinal marijuana cultivation. For more information visit: www.isracann.com .\n\nON BEHALF OF THE BOARD OF DIRECTORS\n\n\u201cDarryl Jones\u201d\n\nDarryl Jones\n\nChief Executive Officer and President\n\nThe CSE does not accept responsibility for the adequacy or accuracy of this release.\n\nAll statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ, materially from the Company\u2019s expectations are disclosed in the Company\u2019s documents filed from time to time with the Canadian Securities Exchange, the British Columbia Securities Commission, the Ontario Securities Commission and the Alberta Securities Commission.", "description": "", "authors": ["Atlas Cloud Enterprises", "Atlas Blockchain Group Inc."], "top_image": "http://www.globenewswire.com/Attachment/LogoDisplay/564326?filename=564326.jpg&size=1", "published_at": "2019-10-11"}